Faeth Therapeutics Inc Com (New) (FTH:NASDAQ) closed at $18.80 on October 16, 2026, down 8.74% on the day. The stock trades 55.4% below its 52-week high of $42.14 and 152.3% above its 52-week low of $7.45. Over the past year, it gained 116.2%. Faeth Therapeutics Inc Com (New) is part of the Health Care sector.
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -11.40% | -39.84% | -26.92% | -34.37% | +116.16% |
In 204 trading sessions since December 23, 2025, FTH closed higher on 96 days (47%). Its best day was February 18, 2026 (+187.51%) and its worst was June 2, 2026 (-18.67%). The stock moved 10% or more in a single session 26 times. It opened at least 5% above the previous day's high 5 times.
Sensei Biotherapeutics, Inc. (Nasdaq: SNSE) is a clinical-stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients. Following the acquisition of Faeth Therapeutics, Sensei's lead program is PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. Sensei is also completing a Phase 1/2 trial of solnerstotug, its V-domain Ig suppressor of T cell activation (VISTA) inhibitor, in patients with advanced solid tumors.
Find more stocks like FTH with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.